|
1 |
Correction: Mild motor signs and depression: more than just medication side effects?
Enthalten in European archives of psychiatry and clinical neuroscience 21.5.2025: 1
|
|
|
|
2 |
Mild motor signs and depression: more than just medication side effects?
Enthalten in European archives of psychiatry and clinical neuroscience 25.4.2025: 1-7
|
|
|
3 |
Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers
Möller, Hans-Jürgen. - Würzburg : Universität Würzburg, 2024
|
|
|
|
4 |
Die Rolle von Phytotherapie bei COVID-19-assoziierter Angst und Depression
Enthalten in Zeitschrift für Phytotherapie Bd. 45, 2024, Nr. 04: 148-156
|
|
|
|
5 |
Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data
Enthalten in European archives of psychiatry and clinical neuroscience 25.10.2024: 1-15
|
|
|
|
6 |
Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy
Enthalten in Wiener klinische Wochenschrift 17.4.2024: 1-14
|
|
|
|
7 |
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial
Enthalten in European archives of psychiatry and clinical neuroscience 1.4.2024: 1-11
|
|
|
|
8 |
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
Enthalten in European archives of psychiatry and clinical neuroscience 30.1.2023: 1-14
|
|
|
|
9 |
ABCB1 variants and sex affect serotonin transporter occupancy in the brain
Enthalten in Molecular psychiatry 7.9.2022: 1-8
|
|
|
|
10 |
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
Enthalten in European archives of psychiatry and clinical neuroscience 9.3.2022: 1-13
|
|
Administration
